|
A relatively small share (14%) adults in households
affected by COVID-19 say they tried to get Paxlovid, the anti-viral
prescription pill used to treat COVID-19. Similarly, among those
households affected by the flu, 16% say they tried to get Tamiflu, an
antiviral prescription medicine used to treat the flu.
Amid media reports of
shortages of over-the-counter medicines often used to treat symptoms of
these ailments, the survey finds that 75% of adults in affected
households tried to obtain over-the-counter medicines such as Tylenol
or cough syrup, including about one in five (representing 6% of all
adults) who say they had difficulties getting that medicine.
News about the three viruses also made some people more likely to take
preventive measures such as wearing a mask in public (31%), avoiding
large gatherings (26%), traveling less (20%), or avoiding eating
indoors at restaurants (18%).
People who say they are immunocompromised are more likely than those
who aren’t to take many of those extra precautions. In addition, Black
and Hispanic adults are more likely than White adults, and Democrats
are more likely than Republicans, to say they are more likely to modify
their behavior.
Nearly 3 in 10 Adults Now Say They’ve Gotten Updated Bivalent
Booster Shot
As the federal
government prepares to end its public health emergency declaration, the
latest survey finds nearly three in ten (28%) adults report having
received an updated COVID-19 bivalent vaccine booster shot, up slightly
from December (22%). The increase largely reflects a shift in booster
rates among Republicans (from 12% in December to 20% in January, though
Democrats still are twice as likely to have gotten the updated booster
(39%).
Among high-risk groups, nearly half
(47%) of adults at least 65 years old, and about a third (36%) of those
who are immunocompromised, say they have already received a bivalent
booster dose.
Those who already received a bivalent
booster are eager to get an additional booster in the future. The vast
majority (86%) say that getting another shot is important to them, and
just over half (54%) say they are waiting for the Centers for Disease
Control and Prevention (CDC) to issue new guidelines to make them
eligible for another booster.
|
No comments:
Post a Comment